Arsenal Capital Partners

Arsenal Capital Partners is a New York-based private equity firm that has operated for 25 years building and growing companies in two concentrated sectors: specialty industrials and healthcare. With over $10 billion in institutional funds raised and more than 320 platform and add-on transactions completed, Arsenal is not a generalist PE firm seeking broad market exposure. Its model centers on acquiring and actively building middle-market businesses where the team brings deep scientific, technical, and domain expertise to create market positions of strategic importance.

Arsenal’s two practice areas define exactly where it deploys capital:

• Healthcare: pharma services, healthcare technology, and clinical research infrastructure
• Industrial Growth: innovative materials, polymers and packaging, and industrial technologies

The firm partners closely with management teams to craft growth strategies, not simply apply financial engineering. Portfolio exits include sales to Henkel, Leggett and Platt, and CenterWell, which reflect the type of strategic acquirers Arsenal targets as endpoints for its companies.

For family offices evaluating Arsenal as a potential fund investment or co-investment partner, the relevant question is fit: Arsenal raises institutional funds and does not publicly disclose fund terms, minimum commitments, or LP-facing terms on its website. Its investor base appears to be institutional rather than individual or family office-oriented, and there is no stated family office program or co-investment platform visible on the site. Family offices seeking private equity exposure in healthcare or industrial sectors would need to engage directly to determine whether access is available and on what terms.